Coronary Vasospasm in Men. The Chest Pain That Standard Testing Misses.

A 44-year-old man wakes at 3 a.m. with crushing chest pressure radiating to his left arm. He calls 911. In the emergency department, his troponin is negative, his EKG has returned to normal, and his stress test the following week shows no inducible ischemia. The cardiologist discharges him with a diagnosis of atypical chest pain and reassurance that his heart is structurally normal. Six weeks later, the same episode happens again, same time, same severity.

He does not have obstructive coronary disease. What he has is coronary vasospasm, and it is one of the most underdiagnosed causes of real, dangerous angina in men.

What Coronary Vasospasm Is

Coronary vasospasm is a transient, severe constriction of a coronary artery that dramatically reduces or completely stops blood flow to a portion of heart muscle. Unlike the slow progressive obstruction of atherosclerotic plaque, vasospasm occurs rapidly, is typically reversible, and happens in arteries that may appear structurally normal or only mildly diseased on standard imaging.

The clinical syndrome of coronary vasospasm that occurs at rest, often at night or in the early morning hours, with transient ST-segment elevation on EKG during the episode, is called Prinzmetal angina or variant angina, named after the cardiologist Myron Prinzmetal who described it systematically in 1959. The broader category includes spasm that occurs in patients with underlying atherosclerosis, spasm triggered by specific agents or stressors, and mixed patterns where both fixed obstruction and dynamic vasospasm contribute to symptoms.

The mechanism involves transient hyperreactivity of vascular smooth muscle in the coronary arterial wall. When triggered, the smooth muscle contracts excessively, abruptly narrowing or closing the arterial lumen. The result is myocardial ischemia, chest pain, and EKG changes that can include dramatic ST elevation identical to what is seen in an acute STEMI. If the spasm is prolonged and severe, it can cause actual myocardial infarction, life-threatening arrhythmias, or sudden cardiac death.

How Vasospasm Differs from Obstructive Coronary Disease

Understanding what makes vasospasm different from the more familiar pattern of obstructive coronary artery disease is essential for understanding why it is so frequently missed.

In obstructive coronary artery disease, atherosclerotic plaque builds up within the coronary artery wall over years, progressively narrowing the lumen. Blood flow is reduced in proportion to the degree of stenosis, and the obstruction is worst during exertion when myocardial oxygen demand rises and a narrowed artery cannot supply sufficient flow. The classic presentation is exertional chest pain or pressure that is reproducible, comes on reliably at a predictable level of physical activity, and resolves with rest within minutes.

Standard diagnostic testing is calibrated to detect this pattern. Exercise stress testing works by pushing heart rate and blood pressure up to provoke ischemia in territories supplied by significantly narrowed arteries. Nuclear stress testing adds perfusion imaging to localize the ischemic territory. These tests are highly sensitive for significant fixed obstructive lesions, typically those causing at least 70 percent stenosis of a major coronary artery.

Coronary vasospasm is almost the opposite in its behavior. The arteries may be entirely normal or only mildly diseased at rest and during exercise. Spasm occurs spontaneously, often at rest, during sleep, or upon awakening. It is triggered not by increased demand but by triggers that provoke smooth muscle hyperreactivity. A standard exercise stress test in a patient with vasospasm typically shows no abnormality because there is no fixed obstruction to unmask, and the test does not reproduce the conditions that trigger spasm. The test returns as normal, the patient is reassured, and the underlying cause goes undiagnosed.

Who Gets Coronary Vasospasm

Coronary vasospasm has a distinct epidemiological profile compared to obstructive coronary artery disease. While obstructive CAD increases monotonically with age and cardiovascular risk factors, vasospasm has a somewhat different distribution.

Age: Vasospasm most commonly presents in people between the ages of 40 and 70, with a peak in the fifth and sixth decades. It is less common at the extremes of age compared to obstructive disease.

Sex: Classical Prinzmetal angina was initially described as more common in women, particularly in the context of coronary spasm with normal coronary arteries. However, in populations where coronary angiography is performed, vasospasm in men is well-recognized, particularly in Japanese and Asian populations where the prevalence appears higher than in Western populations. Among men presenting with acute chest pain and angiographically normal or near-normal coronary arteries, vasospasm is a leading diagnosis.

Smoking: Smoking is the most consistently identified risk factor for coronary vasospasm. Nicotine and the other vasoactive constituents of cigarette smoke increase vascular smooth muscle reactivity. Men who smoke and present with atypical chest pain patterns consistent with vasospasm are particularly warranting of evaluation for this diagnosis. 4 / Promising

Cocaine use: Cocaine is one of the most potent triggers of coronary vasospasm known. Cocaine blocks norepinephrine reuptake, producing intense sympathetic stimulation and direct coronary vasoconstriction. Cocaine-associated myocardial infarction in young men with otherwise normal coronary arteries frequently involves vasospasm as a primary or contributing mechanism. This is a critical history item in any young man presenting with chest pain or myocardial infarction.

Cold exposure: Cold temperatures provoke adrenergic vasoconstriction systemically and can trigger coronary spasm in susceptible individuals. Men who notice chest pain or discomfort specifically when walking into cold air or exercising outdoors in winter should mention this symptom pattern to their cardiologist, as it is a recognized vasospasm trigger.

Emotional stress and hyperventilation: Acute psychological stress and hyperventilation-induced alkalosis can both trigger coronary spasm in susceptible individuals. The early-morning timing of many vasospasm episodes may relate in part to the adrenergic surge that accompanies awakening from sleep.

Certain medications and substances: Ergot derivatives, used in migraine therapy, are potent coronary vasoconstrictors and should be avoided in men known to have vasospasm. 5-hydroxytryptamine agonists (triptans), used in migraine treatment, can also provoke spasm in susceptible patients. Discuss all medications, including migraine treatments, with your cardiologist if coronary vasospasm is suspected.

Alcohol withdrawal: Sympathetic activation during alcohol withdrawal can trigger coronary spasm. This is a poorly recognized but real clinical scenario in men presenting with chest pain in the setting of alcohol dependence.

The Typical Presentation in Men

The classic presentation of Prinzmetal angina in men is chest pain that occurs at rest, frequently in the early morning hours between midnight and 8 a.m. The pain is typically severe and ischemic in character: pressure, tightness, or heaviness in the mid-chest, sometimes radiating to the jaw, left arm, or back. An episode typically lasts 5 to 30 minutes before resolving spontaneously.

What makes this pattern distinctive is the rest component and the timing. Unlike stable angina, which is reliably triggered by a predictable level of exertion, vasospasm episodes occur in the absence of physical activity and often wake the patient from sleep. The man who describes being awakened at 3 a.m. with severe chest pressure that resolved on its own over 15 to 20 minutes, with no episode during a stress test the following day, is describing a pattern highly suspicious for vasospasm.

Associated features during an episode can include palpitations (from ventricular arrhythmias triggered by ischemia), diaphoresis, and in severe cases, syncope or presyncope from hemodynamically significant arrhythmias. Sudden cardiac death from ventricular fibrillation during a vasospasm episode is rare but documented, particularly in patients with spasm of multiple vessels simultaneously or in those who continue to smoke.

Between episodes, the patient typically feels completely normal. There are no exertional symptoms, no dyspnea on climbing stairs, no limitation on activities. This intermittent pattern of severe ischemic episodes with complete resolution and normal function in between is a hallmark that distinguishes vasospasm from most other causes of recurrent chest pain.

Why Standard Testing Misses It

The standard diagnostic pathway for chest pain in a man without known heart disease typically proceeds: EKG, troponin, and depending on the clinical picture, a stress test. In coronary vasospasm, all three components of this pathway can be entirely normal.

The EKG shows ST elevation or depression only during the spasm itself. If the episode has resolved by the time the patient reaches the emergency department, the EKG will be normal. If troponin is checked early after a brief episode, it is typically negative because the spasm was not prolonged enough to produce measurable myocardial necrosis.

The stress test, as described above, is designed to provoke ischemia in fixed obstructive lesions by increasing heart rate and myocardial oxygen demand. It does not mimic the conditions that trigger vasospasm. A patient with pure coronary vasospasm can complete a maximal stress test to target heart rate with no EKG changes and no symptoms, then go home and wake up at 3 a.m. in the middle of a spasm episode.

Coronary angiography (cardiac catheterization), the definitive test for obstructive coronary disease, also frequently returns as normal in vasospasm. The procedure is performed while the patient is awake, typically relaxed, and in a warm catheterization laboratory. The conditions that trigger spasm are not present. The arteries appear normal or near-normal. The report says “no significant obstructive coronary artery disease” and the patient is reassured.

This is where the diagnostic pathway often ends, with the patient carrying an unexplained chest pain diagnosis and no clear plan. A thorough cardiologist who suspects vasospasm does not stop at a normal angiogram. The evaluation for vasospasm requires either catching an episode on an EKG (through ambulatory monitoring), reproducing the spasm during catheterization using a provocative test, or both.

How Vasospasm Is Evaluated

When a cardiologist suspects coronary vasospasm based on the clinical history, the evaluation focuses on two objectives: confirming that an episode is vasospasm and not an alternative diagnosis, and ruling out concurrent obstructive coronary disease that may be contributing.

Ambulatory EKG monitoring (Holter monitoring or an event recorder) is often the first step. If a patient can capture an episode on a monitor at home, the EKG during the episode is diagnostic. The hallmark finding is transient ST elevation in a coronary distribution that resolves completely when the episode ends. This is one of the most diagnostically specific EKG findings in cardiology when observed in the clinical context of rest angina.

The challenge is that episodes may be infrequent and difficult to capture on a standard 24 or 48-hour Holter. Longer-term ambulatory monitors, worn for 14 to 30 days, significantly increase the likelihood of capturing an episode. Implantable loop recorders, inserted under the skin, can monitor continuously for years and have documented vasospasm in patients with very infrequent episodes.

Coronary angiography is frequently performed to rule out obstructive disease as the primary cause. The finding of normal or minimally diseased coronary arteries in a man with a classic vasospasm history moves the probability toward vasospasm significantly.

Provocative testing during catheterization, as noted above, can definitively diagnose vasospasm by pharmacologically triggering and documenting the spasm. The threshold for this testing varies by center and operator experience. It is more widely used in Japan and parts of Europe than in North American practice, where it remains less standardized.

Management and Triggers to Avoid

The most important step in managing coronary vasospasm is identifying and eliminating triggers where possible.

Smoking cessation is the single most important modifiable risk factor. Continuing to smoke when vasospasm has been diagnosed is a significant driver of ongoing episodes and complications. Your cardiologist will address this directly.

Cocaine avoidance is absolute. There is no safe level of cocaine use in a man with documented coronary vasospasm.

Cold exposure management includes layering appropriately in cold weather, covering the face and mouth, and avoiding sudden transition from warm to cold environments in individuals who have identified cold as a trigger.

Alcohol moderation and addressing alcohol dependence, if present, removes a potential trigger and addresses a broader cardiovascular risk factor simultaneously.

Medical management of vasospasm, which your cardiologist will guide based on your individual situation, typically involves medications from the calcium channel blocker class and potentially nitrates, both of which relax vascular smooth muscle and reduce the frequency and severity of spasm. The specific approach is a clinical decision that depends on the severity of symptoms, the documented EKG pattern, and the presence of any concomitant cardiovascular conditions. 5 / Solid

Regular follow-up with a cardiologist familiar with vasospasm is essential. The condition can evolve over time, episodes can cluster or become more frequent, and the risk of serious arrhythmia during an episode warrants ongoing monitoring and management adjustment as needed.

The Overlap With Microvascular Angina

It is worth knowing that coronary vasospasm exists on a spectrum with other forms of non-obstructive coronary artery disease, including coronary microvascular dysfunction. Microvascular angina involves abnormal function of the small resistance vessels in the coronary circulation rather than the large epicardial arteries visualized on angiography. Some patients have elements of both epicardial spasm and microvascular dysfunction, and the two conditions can be difficult to separate clinically.

The broader diagnostic category is now often referred to as ANOCA (Angina with Non-Obstructive Coronary Arteries). This umbrella term encompasses vasospasm, microvascular dysfunction, and related conditions. The recognition of ANOCA as a distinct and important syndrome has improved in recent years, driven partly by the COVADIS group’s international consensus criteria for diagnosing vasospastic angina and partly by growing awareness among cardiologists that a normal angiogram does not rule out a real and potentially dangerous coronary diagnosis.

Men who have been told their heart is normal after an angiogram but continue to have episodes of rest chest pain should ask their cardiologist specifically about ANOCA, vasospasm evaluation, and whether referral to a center with experience in non-obstructive coronary disease is warranted. 3 / Early

Summary

Coronary vasospasm is a real, clinically significant cause of chest pain and potential cardiac events in men, and it is missed far more often than it should be. The combination of atypical presentation, normal standard testing, and episodic nature conspires to leave many men without a diagnosis for months or years.

The key points for a man who suspects this may apply to him: the pattern of rest chest pain, especially nocturnal or early morning, with normal stress testing and normal or near-normal coronary arteries on angiography, is highly suspicious. Smoking and cocaine use are the most modifiable risk factors. Standard stress testing does not rule out vasospasm. A cardiologist with experience in non-obstructive coronary artery disease and provocative testing is the right specialist to evaluate this presentation.

If episodes have been unexplained and recurrent, getting a definitive evaluation is worth pursuing. Vasospasm that is correctly identified and managed can be well-controlled. Left undiagnosed, it carries real risk.

Frequently Asked Questions

Q: How is coronary vasospasm different from a heart attack? A: Both coronary vasospasm and a heart attack (myocardial infarction) involve reduced blood flow to heart muscle, and severe vasospasm can cause actual myocardial damage. The key difference is the mechanism: a heart attack typically involves a ruptured atherosclerotic plaque forming a clot that blocks an artery, while vasospasm is a sudden severe contraction of the arterial wall in an artery that may be structurally normal. Vasospasm episodes usually resolve spontaneously or with nitroglycerin, whereas a STEMI caused by clot requires urgent mechanical opening of the artery. If you experience severe chest pain, emergency evaluation is required regardless of whether vasospasm is suspected.

Q: Can coronary vasospasm cause sudden cardiac death? A: Yes, though this is uncommon. Severe vasospasm, particularly involving multiple coronary arteries simultaneously or occurring in the setting of significant underlying disease, can trigger ventricular fibrillation. This is more likely in patients who continue to smoke, use cocaine, or have poorly controlled episodes. Patients with documented high-risk vasospasm patterns are evaluated by their cardiologist for arrhythmia risk and managed accordingly. Successful identification and treatment of vasospasm significantly reduces this risk.

Q: Will a stress test diagnose coronary vasospasm? A: Standard exercise or pharmacological stress tests are not designed to detect vasospasm and frequently return as normal in patients who have it. Stress tests detect fixed obstructive lesions by increasing myocardial demand; they do not reproduce the rest triggers of vasospasm. The most reliable way to capture vasospasm is ambulatory EKG monitoring during a spontaneous episode or provocative testing during cardiac catheterization. Discuss these options with your cardiologist if vasospasm is suspected and standard testing has been unrevealing.

Q: Is coronary vasospasm more common in men or women? A: Both men and women get coronary vasospasm, and the epidemiology varies somewhat by population. In Western series, vasospasm with normal coronary arteries has historically been described somewhat more often in women. In Japanese and other Asian populations, vasospasm overall appears more prevalent, and men are well-represented. Among men presenting with acute chest pain syndromes and angiographically normal arteries, vasospasm is a leading explanation and should not be assumed to be a diagnosis that applies only to women.

Q: What lifestyle changes help prevent coronary vasospasm episodes? A: The most impactful change for men who smoke is smoking cessation. Smoking is the most consistently identified modifiable risk factor for vasospasm and is directly linked to increased episode frequency and severity. Avoiding cocaine completely is essential if relevant. Minimizing cold exposure, managing stress, and avoiding known pharmacological triggers are also important. Your cardiologist will guide the medical management component, which in combination with lifestyle modification typically achieves good control of episode frequency in most patients.

The Signal Check is fifteen questions mapping the male cardiovascular risk pattern, including the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.